Dražen Belina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dražen Belina has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Željko Đurić
Department of cardiac surgery, UHC Zagreb
3 shared publications - Darko Anić
Department for Congenital Heart Surgery, University Clinic for Heart Surgery, Clinical Hospital Center Zagreb, University of Zagreb School of Medicine, Kispaticeva, Croatia
2 shared publications - Irena Ivanac Vranešić
Department of Cardiovascular Diseases, University Hospital Center Zagreb , Kispaticeva 12, Zagreb 10000
2 shared publications - Kristina Marić Bešić
Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia
2 shared publications - Toni Matić
19Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia
2 shared publications - Ana Veljača1 shared publication
Latest Publications
- 1 April 2025
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 20 (5-6) , 172
Infective endocarditis of the Melody valve in a patient with absent pulmonary valve syndrome
- 1 April 2025
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 20 (5-6) , 172
Infective endocarditis of the Melody valve in a patient with absent pulmonary valve syndrome
- 1 April 2025
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 20 (5-6) , 117-118
Stented bioprostheses in the pulmonary position - a single center retrospective study
- 1 April 2025
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 20 (5-6) , 117-118
Stented bioprostheses in the pulmonary position - a single center retrospective study
- Open Access
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A145
346 Bivalirudin use during continuous renal replacement therapy in a 2.5-year-old girl suffering from cardiomyopathy and receiving VAD support
Ventricle assist devices (VAD) are often the only bridge to heart transplantation in children with deteriorating cardiomyopathies. Berlin Heart EXCOR Pediatric is registered for children and can be used to support the function of right, left or both ventricles. Despite the use of the ‘Edmonton protocol’ to guide the anticoagulation management, thromboembolism and hemorrhage are common adverse effects. Moreover, prolonged intravenous heparin use is often complicated with heparin induced thrombocytopenia (HIT), which leads to a conclusion that new antithrombotic strategies are needed, such as use of direct inhibitor of thrombin, i.e. bivalirudin. In our patient, a 2.5-year-old girl with restrictive cardiomyopathy, heart decompensation occurred after a viral infection (with later confirmation of parvovirus B19 myocarditis). Mechanical circulatory support with VA ECMO was started, with an implantation of LVAD Berlin Heart 3 weeks later. She spent 125 days on VAD support waiting for a heart transplantation. The ‘Edmonton protocol’ was followed for anticoagulation and anti-aggregation therapy guidance (warfarin, acetylsalicylic acid and clopidogrel). She suffered multiple complications: bilateral pleural effusions, middle cerebral artery thrombosis, fibrin over the VAD cannula, intracranial hemorrhage and shunt meningitis. During an episode of septic shock, acute renal failure occurred, requiring continuous veno-venous hemodiafiltration that has been continued for 21 days. Prolonged thrombocytopenia led to diagnosis of HIT, so heparin was replaced with bivalirudin (direct thrombin inhibitor) as anticoagulation therapy, in addition to acetylsalicylic acid and clopidogrel. Bivalirudin use is easily monitored by APTT and ACT and the dosage is modified according to it. Bivalirudin has been used for 16 days along with CVVHDF, without hemofilter occlusion or fibrin deposits on cannulas of BH Excor. According to our experience and cases described in literature, bivalirudin has been used in children with VAD Berlin Heart EXCOR with positive outcomes. In addition, successful use of bivalirudin for anticoagulation during continuous renal replacement was associated with longer hemofilter survival time and less hemorrhagic and/or thrombotic events. On the other hand, there are some disadvantages such as lack of pediatric experience, no available antidote and high price. From all of the above, we may conclude that new experiences and investigations are needed and alternative anti-thrombotic drugs, such as bivalirudin, should be considered for patients with VAD and CVVHDF.
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A145
Open Access346 Bivalirudin use during continuous renal replacement therapy in a 2.5-year-old girl suffering from cardiomyopathy and receiving VAD support
Ventricle assist devices (VAD) are often the only bridge to heart transplantation in children with deteriorating cardiomyopathies. Berlin Heart EXCOR Pediatric is registered for children and can be used to support the function of right, left or both ventricles. Despite the use of the ‘Edmonton protocol’ to guide the anticoagulation management, thromboembolism and hemorrhage are common adverse effects. Moreover, prolonged intravenous heparin use is often complicated with heparin induced thrombocytopenia (HIT), which leads to a conclusion that new antithrombotic strategies are needed, such as use of direct inhibitor of thrombin, i.e. bivalirudin. In our patient, a 2.5-year-old girl with restrictive cardiomyopathy, heart decompensation occurred after a viral infection (with later confirmation of parvovirus B19 myocarditis). Mechanical circulatory support with VA ECMO was started, with an implantation of LVAD Berlin Heart 3 weeks later. She spent 125 days on VAD support waiting for a heart transplantation. The ‘Edmonton protocol’ was followed for anticoagulation and anti-aggregation therapy guidance (warfarin, acetylsalicylic acid and clopidogrel). She suffered multiple complications: bilateral pleural effusions, middle cerebral artery thrombosis, fibrin over the VAD cannula, intracranial hemorrhage and shunt meningitis. During an episode of septic shock, acute renal failure occurred, requiring continuous veno-venous hemodiafiltration that has been continued for 21 days. Prolonged thrombocytopenia led to diagnosis of HIT, so heparin was replaced with bivalirudin (direct thrombin inhibitor) as anticoagulation therapy, in addition to acetylsalicylic acid and clopidogrel. Bivalirudin use is easily monitored by APTT and ACT and the dosage is modified according to it. Bivalirudin has been used for 16 days along with CVVHDF, without hemofilter occlusion or fibrin deposits on cannulas of BH Excor. According to our experience and cases described in literature, bivalirudin has been used in children with VAD Berlin Heart EXCOR with positive outcomes. In addition, successful use of bivalirudin for anticoagulation during continuous renal replacement was associated with longer hemofilter survival time and less hemorrhagic and/or thrombotic events. On the other hand, there are some disadvantages such as lack of pediatric experience, no available antidote and high price. From all of the above, we may conclude that new experiences and investigations are needed and alternative anti-thrombotic drugs, such as bivalirudin, should be considered for patients with VAD and CVVHDF.
- 6 August 2020
- Published by SAGE Publications in Perfusion
- Vol. 36 (3) , 305-307
Extracorporeal cardiopulmonary resuscitation with low pump flow for blocked modified Blalock–Taussig shunt followed by spontaneous recanalization
A 2-week-old male newborn with a double inlet left ventricle developed a cardiac arrest following modified Blalock–Taussig anastomosis in pediatric intensive care unit. Probable causes of the arrest were hemodynamic instability and thrombosed shunt, which was later recanalized on extracorporeal membrane oxygenation therapy, which was successfully used with a pump flow lower than recommended in these patients—without the shunt clip, but without any complications.
- 6 August 2020
- Published by SAGE Publications in Perfusion
- Vol. 36 (3) , 305-307
Extracorporeal cardiopulmonary resuscitation with low pump flow for blocked modified Blalock–Taussig shunt followed by spontaneous recanalization
A 2-week-old male newborn with a double inlet left ventricle developed a cardiac arrest following modified Blalock–Taussig anastomosis in pediatric intensive care unit. Probable causes of the arrest were hemodynamic instability and thrombosed shunt, which was later recanalized on extracorporeal membrane oxygenation therapy, which was successfully used with a pump flow lower than recommended in these patients—without the shunt clip, but without any complications.
- Open Access
- 27 April 2020
- Published by Faculty of Medicine Osijek in Southeastern European medical journal
- Vol. 4 (1) , 40-48
Decrease of Environmental Temperature May Trigger the Onset of Acute Aortic Dissection
Aim: The most important risk factors for a Stanford type A acute aortic dissection (AAD) include arterial hypertension and connective tissue disorders, while numerous studies have identified meteorology factors, such as environmental temperature also play an important role. The aim of this study is to explore the relationship between environmental temperature and the frequency of AAD surgically threated over a 12-year period at a Croatian university hospital. Methods: This is a retrospective, monocenter observational study conducted at the University Hospital Centre Zagreb. The study includes 134 patients who were threated surgically for Stanford type A AAD between January 2001 and December 2012. Temperature categories (low, moderate and high) were based on the calculated monthly average environmental temperature and standard deviation given from official daily environmental temperatures for the respective period. Results: The results show a higher frequency of AAD in days of low temperature compared to days of moderate temperature or high temperature. The frequency of days with AAD was somewhat higher in moderate than high temperature category, but the difference is not statistically significant. The relative frequency of AAD for low, moderate and high temperature categories were 4.55, 2.96 and 1.93, respectively. Conclusion: Environmental temperature drop induces stressful adaptive body response, including an additional hemodynamic load and increase in arterial blood pressure, strong enough to trigger the AAD-etiopathogenesis. Furthermore, our findings indicate that body response to environmental heat may differ from a response to reduced environmental temperature, due to observed small number of events in days of high temperature.
- 27 April 2020
- Published by Faculty of Medicine Osijek in Southeastern European medical journal
- Vol. 4 (1) , 40-48
Open AccessDecrease of Environmental Temperature May Trigger the Onset of Acute Aortic Dissection
Aim: The most important risk factors for a Stanford type A acute aortic dissection (AAD) include arterial hypertension and connective tissue disorders, while numerous studies have identified meteorology factors, such as environmental temperature also play an important role. The aim of this study is to explore the relationship between environmental temperature and the frequency of AAD surgically threated over a 12-year period at a Croatian university hospital. Methods: This is a retrospective, monocenter observational study conducted at the University Hospital Centre Zagreb. The study includes 134 patients who were threated surgically for Stanford type A AAD between January 2001 and December 2012. Temperature categories (low, moderate and high) were based on the calculated monthly average environmental temperature and standard deviation given from official daily environmental temperatures for the respective period. Results: The results show a higher frequency of AAD in days of low temperature compared to days of moderate temperature or high temperature. The frequency of days with AAD was somewhat higher in moderate than high temperature category, but the difference is not statistically significant. The relative frequency of AAD for low, moderate and high temperature categories were 4.55, 2.96 and 1.93, respectively. Conclusion: Environmental temperature drop induces stressful adaptive body response, including an additional hemodynamic load and increase in arterial blood pressure, strong enough to trigger the AAD-etiopathogenesis. Furthermore, our findings indicate that body response to environmental heat may differ from a response to reduced environmental temperature, due to observed small number of events in days of high temperature.
- 1 July 2012
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 144 (1) , 263-264
Penetrating injury to the right side of the heart without hemodynamic compromise
- 1 July 2012
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 144 (1) , 263-264
Penetrating injury to the right side of the heart without hemodynamic compromise